{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Wilmington",
      "state": "DE",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "73538",
      "recalling_firm": "AstraZeneca Pharmaceuticals LP",
      "address_1": "1800 Concord Pike, P.O. Box 15437",
      "address_2": "Health Services Medical FOC 1",
      "postal_code": "19850-5437",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "N/A",
      "distribution_pattern": "US: Nationwide Including Puerto Rico",
      "recall_number": "D-0781-2016",
      "product_description": "Tudorza Pressair (aclindinium bromide inhalation powder), 400 mcg per actuation, 60 Metered Doses per Inhaler, Rx Only. Manufactured for: AstraZeneca Pharmaceuticals LP, Wilmington, DE 19850. Manufactured by: Forest Laboratories, Ireland Limited, Dublin 17 Ireland. Product of Spain. NDC: 0310-0800-60.",
      "product_quantity": "148,331 Inhalers",
      "reason_for_recall": "Defective Delivery System: Some units have actuation counters set to a number other than 60.",
      "recall_initiation_date": "20160205",
      "center_classification_date": "20160322",
      "termination_date": "20170620",
      "report_date": "20160330",
      "code_info": "Lot # 1144394, Expiry: 04/2018; Lot # 1145539, Expiry: 04/2018; Lot # 1145868, Expiry: 05/2018."
    }
  ]
}